IPO Analysis: Antony Waste Handling Cell IPO Analysis: Antony Waste Handling Cell Antony Waste Handling Cell (Antony), a Mumbai-based company engaged in municipal solid waste management is tapping the primary capital market with its IPO. Read on to find if you should subscribe to the issue.
IPO Analysis: SBI Cards & Payment Services IPO Analysis: SBI Cards & Payment Services SBI Cards and Payment Services (SBIC) a subsidiary of SBI, engaged in credit card services, is entering the capital market with its Initial Public Offer (IPO) of equity shares of Rs 10 each. Read on to find if you should subscribe to the issue.
IPO Analysis: Prince Pipes and Fittings IPO Analysis: Prince Pipes and Fittings Prince Pipes and Fittings engaged in the manufacturing of polymer pipes is entering the primary capital market with its initial public offer of equity shares of Rs 10 each. Read on to find if you should subscribe to the issue.
IPO Analysis: Ujjivan Small Finance Bank IPO Analysis: Ujjivan Small Finance Bank Ujjivan Small Finance Bank , a small finance bank, promoted by Ujjivan Financial Services, an NBFC that began operations in 2005, is entering the capital market with its initial public offering. Read on to find details.
IPO Analysis: CSB Bank IPO Analysis: CSB Bank CSB Bank, one of the oldest private sector banks in India, with a history of over 98 years, is entering the capital market with its initial public offering. Read on to find if you should subscribe to it.
Cipla receives final USFDA approval for Efavirenz Cipla receives final USFDA approval for Efavirenz Nikita Singh / 20-Jun-2018, 04:21 PM / Article rating: 4.3 Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).
Alembic continues rally as Panelav unit receives EIR Alembic continues rally as Panelav unit receives EIR Nikita Singh / 15-Jun-2018, 12:36 PM / Article rating: 3.0 The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association.
Overnight Digest: Stocks to look out for on June 15 Overnight Digest: Stocks to look out for on June 15 Nikita Singh / 14-Jun-2018, 06:33 PM / Article rating: 5.0 The stocks that are likely to record significant movement on the bourses on Friday, June 15 are HIL Limited, Wipro Limited, Maha Rashtra Apex Corporation Limited and Hind Aluminium Industries Limited.
Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Nikita Singh / 14-Jun-2018, 12:52 PM / Article rating: 3.5 The share price of Cipla surged by nearly 2 per cent in the early trade on Thursday as the company received the USFDA approval for Isoproterenol Hydrochloride injection, a generic version of Hospira Inc’s Isuprel injection.
Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Nikita Singh / 14-Jun-2018, 12:29 PM / Article rating: 5.0 Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules.